Skip to main content

We’re not only bridging the barrier between mind and body, but we’re also making headlines with our innovative digital therapeutics.

PRESS RELEASES AND ANNOUNCEMENTS

metaMe Health partners with Launchit Ventures to market Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with IBS, in Canada

metaMe Health licenses rights to commercialization of Regulora® in Canada to Launchit Ventures, Inc. to expedite the availability of Regulora… Read more

Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment 

metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the… Read more

metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome

Princeton, NJ, and Chicago, IL, United States, March 22, 2022 – Indegene, a technology-led global healthcare solutions provider, and metaMe Health… Read more


COMPANY AND INDUSTRY NEWS

To better understand gastropsychology, Healio Gastroenterology spoke with experts about its place in a patient’s care plan, how to implement it into… Read more

Listen to UNC-Chapel Hill’s Dr. Olafur Palsson, originator of the gold-standard North Carolina treatment protocol for gut-directed hypnotherapy (GDH)… Read more

Hear metaMe Health CEO Tim Rudolphi discuss the founding story of our company, the impact of gut-directed hypnotherapy, and the commercialization of PDTs. Listen… Read more

STAY CONNECTED TO THE FUTURE OF
PRESCRIPTION DIGITAL THERAPIES

Join our mailing list: